Prospective Observational Trial to Evaluate Quality of Life After Neoadjuvant or Definitive Chemoradiation in Patients With Esophageal Cancer
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY
Prospective observational study to evaluate the Quality of life based on standardized EORTC questionaires as well as toxicities, functional and oncological outcomes in patients treated with neoadjuvant or definitive chemoradiation for esophageal Cancer.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
View:
• histologically proven esophageal Cancer (SCC or adenocarcinoma) without distant metastases (except supraclavicular nodes)
• indication for neoadjuvant or definitive chemoradiation using either cisplatin/5-FU or carboplatin/paclitaxel with curative intent
• age \>= 18 years
• written informed consent
• ability to answer the standardized questionaires according to the treating physician
Locations
Other Locations
Germany
Department of Radiation Oncology, University Hospital, LMU Munich
RECRUITING
Munich
Contact Information
Primary
Falk Roeder, MD
Falk.Roeder@t-online.de
+49 89 4400
Backup
Franziska Walter, MD
Franziska.Walter@med.uni-muenchen.de
+49 89 4400
Time Frame
Start Date: 2018-10-12
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 60
Treatments
neoadjuvant chemoradiation
Patient with esophageal Cancer treated by neoadjuvant chemoradiation followed by surgery will be longitudinally evaluated by questionaires EORTC QLQ C30, EORTC QLQ OES-18 and EORTC OG-25
definitive chemoradiation
Patient with esophageal Cancer treated by definitive chemoradiation will be longitudinally evaluated by questionaires EORTC QLQ C30, EORTC QLQ OES-18 and EORTC OG-25
Related Therapeutic Areas
Sponsors
Leads: Ludwig-Maximilians - University of Munich